Variant report
Variant | esv3396251 |
---|---|
Chromosome Location | chr20:12809275-12809568 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529097598 | chr20:12809300-12809301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199945180 | chr20:12809313-12809314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200543343 | chr20:12809315-12809316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570367446 | chr20:12809327-12809328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs397728658 | chr20:12809334-12809335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200728791 | chr20:12809386-12809387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375209370 | chr20:12809388-12809389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6109571 | chr20:12809390-12809391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145467088 | chr20:12809405-12809406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374848380 | chr20:12809422-12809423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs578037118 | chr20:12809447-12809448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566824695 | chr20:12809451-12809452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10153999 | chr20:12809458-12809459 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs147604285 | chr20:12809472-12809473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140831391 | chr20:12809505-12809506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529355144 | chr20:12809511-12809512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549486813 | chr20:12809519-12809520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562537839 | chr20:12809521-12809522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6041650 | chr20:12809535-12809536 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs186994232 | chr20:12809558-12809559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:12806600-12809400 | Weak transcription | Fetal Brain Female | brain |
2 | chr20:12808000-12810200 | Enhancers | Fetal Brain Male | brain |
3 | chr20:12808400-12809400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr20:12808600-12809400 | Enhancers | Brain Germinal Matrix | brain |
5 | chr20:12808600-12818200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
6 | chr20:12808800-12809800 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr20:12809000-12816400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr20:12809400-12809800 | Enhancers | Fetal Brain Female | brain |
9 | chr20:12809400-12810200 | Weak transcription | Brain Germinal Matrix | brain |